Synthesis and amphiphilic behavior of N,N-bis-glucosyl-1,5-benzodiazepin-2, 4-dione

Journal of Carbohydrate Chemistry

Volumn 23, Issue 6-7, 2004, Pages 389-401

  Lakhrissi, Brahim ^a   Essassi, El Mokhtar ^b   Massoui, Mohamed ^a   Goethals, Gérard ^c   Lequart, Vincent ^d   Monflier, Eric ^d   Cecchelli, Roméo ^d   Martin, Patrick ^d  

^a IBN TOFAIL UNIVERSITY   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^d UNIVERSITÉ D'ARTOIS   (France)

Author keywords

Glucosyl 1,5 benzodiazepin 2,4 diones; Surface tension; Water solubility

Indexed keywords

EID: 33746280281     PISSN: 07328303     EISSN: 15322327     Source Type: Journal    
DOI: 10.1081/CAR-200039373     Document Type: Article

References (29)

1. Blair, T.; Webb, A. Electronic factors in the structure-activity relations of some 1,4-benzodiazepin-2-ones. J. Med. Chem. 1977, 20, 1206-1210.
2. Sternbach, L. The benzodiazepine story. Prog. Drug Res. 1978, 22, 229-266.
3. Wilms, H.; Claasen, J.; Röhl, C.; Sievers, J.; Deuschl, G.; Lucius, R. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol. Dis. 2003, 14, 417-424.
4. Bock, M.G.; Dipardo, R.M.; Evans, B.E.; Rittle, K.E.; Whitter, W.L.; Garsky, V.M.; Gilbert, K.F.; Leighton, J.L.; Carson, K.L.; Mellin, E.C.; Veber, D.F.; Chang, R.S.L.; Lotti, V.J.; Freedman, S.B.; Smith, A.J.; Patel, S.; Anderson, P.S.; Freidinger, R.M. Development of 1,4-benzodiazepine cholecystokinin type B antagonists. J. Med. Chem. 1978, 36, 4276-4292.
5. Webb, R.R.; Barker, P.L.; Baier, M.; Reynolds, M.E.; Robarge, K.D.; Blackburn, B.K.; Tischler, M.H.; Weese, K.J. Mono-N-alkylation of anthranilamides via qinazolinones. An efficient synthesis of G5598, a benzodiazepine dione gpIIbIIIa antagonist. Tetrahedron Lett. 1994, 35, 2113-2116.
6. Blackburn, B.; Lee, A.; Baier, M.; Kohl, B.; Olivero, A.; Matamoros, R.; Robarge, K.; McDowell, R. From peptide to non-peptide. 3. atropisomeric gpIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus. J. Med. Chem. 1997, 40, 717-729.
7. Morimoto, T.; Hashimoto, K.; Yasumatsu, H.; Tanaka, H.; Fujimura, M.; Kuriyama, M.; Kimura, K.; Takehara, S.; Yamagami, K. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate). Neuropsychopharmacology. 2002, 26 (4), 456-446.
8. Agrawal, V.K.; Sharma, R.; Khadikar, P.V. Quantitative structure - activity relationship studies on 5-phenyl-3-ureido-1,5-benzodiazepine as cholecystokinin-A receptor antagonists. Bioorg. Med. Chem. Let. 2002, 10 (11), 3571-3581.
9. Miyawaki, I.; Moriyasu, M.; Funabashi, H.; Yasuba, M.; Matsuoka, N. Mechanism of clobazam induced thyroidal oncogenesis in male rats. Toxicol. Lett. 2003, 145 (3), 291-301.
10. Miura, Y.; Amano, S.; Torii, R.; Ihar, N. Clobazam shows a different antiepileptic action profile from clonazepam and zonisamide in Ihara epileptic rats. Epilepsy Res. 2002, 49 (3), 189-202.
11. (a) Zellou, A.; Cherrah, Y.; Hassar, M.; Essassi, E.M. Synthesis and pharmacologic study of 1,5-benzodiazepine-2,4-diones and their alkyl derivatives. Ann. Pharm. Fr. 1998, 56, 169-174;
12. (b) Zellou, A.; Cherrah, Y.; Hassar, M.; Essassi, E.M. Synthesis and pharmacologic study of 1,5-benzodiazepine-2,4-dithiones and their alkyl derivatives. Ann. Pharm. Fr. 1998, 56, 175-178.
13. (a) Wilms, H.; Claasen, J.; Röhl, C.; Sievers, J.; Deuschl, G.; Lucius, R. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobio. Dis. 2003, 14 (3), 417-424;
14. (b) Trapani, G.; Laquintana, V.; Latrofa, A.; Ma, J.; Reed, K.; Serra, M.; Biggio, G.; Liso, G.; Gallo, J.M. Peripheral benzodiazepine receptor ligand-melphalan conjugates for potential selective drug delivery to brain tumors. Bioconjugate Chem. 2003, 14 (4), 830-839.
15. Madani, H.; Thompson, A.S.; Threadgill, M.D. An expedient synthesis of 7-O-functionalised pyrrolo[2,1-c][1,4]benzodiazepine-5,11-diones. Tetrahedron. 2002, 58 (40), 8107-8111.
16. Taillefumier, C.; Thielges, S.; Chapleur, Y. Anomeric spiroannelated 1,4-diazepine 2,5-diones from furano exo-glycals: towards a new class of spironucleosides. Tetrahedron. 2004, 60 (10), 2213-2224.
17. Kamal, A.; Ramesh, G.; Srinivas, O.; Ramulu, P. Synthesis and antitumour activity of pyrene-linked pyrrolo [2,1-c][1 and 4]benzodiazepine hybrids. Bioorg. Med. Chem. Let. 2004, 14 (2), 471-474.
18. (a) Grossi, G.; Di Braccio, M.; Roma, G.; Ballabeni, V.; Tognolini, M.; Calcina, F.; Barocelli, E. 5-Benzodiazepines: Part XIII. Substituted 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo[1,2-a][1,5] benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity. Eur. J. Med. Chem. 2002, 37 (12), 933-944;
19. (b) Grossi, G.; Di Braccio, M.; Roma, G.; Vargiu, L.; Mura, M.; Marongiu, M.E. 1,5-benzodiazepines. Part XII. Synthesis and biological evaluation of tricyclic and tetracyclic 1,5-benzodiazepine derivatives as nevirapine analogues. Eur. J. Med. Chem. 2001, 36 (11-12), 935-949.
20. (a) Bouhlal, D.; Godé, P.; Goethals, G.; Massoui, M.; Villa, P.; Martin, P. Synthesis and amphiphilic properties of glycosyl-1,4-benzodiazepin-2, 5-diones. Carbohydr. Res. 2000, 329, 207-214;
21. (b) Bouhlal, D.; Godé, P.; Goethals, G.; Massoui, M.; Villa, P.; Martin, P. Glycosyl-pyrrolo[2,1-c][1,4]benzodiazepin-5,11-diones. Synthesis, tensiactivity and antibacterial activity. Heterocycles. 2001, 55 (2), 303-312.
22. Goethals, G.; Lequart, V.; Martin, P.; Maziere, J.C.; Maziere, C.; Pouillart, P.; Villa, P. Dérivés de saccharides et d'itols possédant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme médicaments dans les pathologies prolifératives tumorales ou bénignes. Fr Patent no 2842518., 2002.
23. Essassi, E.M.; Lamkaddem, A.; Zniber, R. Research on 1,5-benzodiazepines. Synthesis of [4,3-a; 3,4-d]triazolo-1,5-benzodiazepines. Bull. Soc. Chem. Belg. 1991, 100, 277-286.
24. Shriner, R.L.; Boermans, P.G. O-Phenylenemalonamide. J. Am. Chem. Soc. 1944, 66, 1810-1812.
25. Goueth, P.Y.; Ronco, G.; Villa, P. Synthesis of ether-linked di- and trisaccharides derivatives. Part I - Synthesis of disaccharides from 5,6-anhydro-D-glucose derivatives. J. Carbohydr. Chem. 1994, 13, 679-696.
26. (a) Vanbaelinghem, L.; Godé, P.; Goethals, G.; Martin, P.; Ronco, G.; Villa, P. Synthesis of 1,2-O-isopropylidene-3,5-O-propylidene-α-D- glucofuranose as a convenient precurseor of both 6-O-alkyl and 6-O-glycidyl-D-glucose amphiphiles. Carbohydr. Res. 1998, 311, 89-94;
27. (b) Christensen, J.E.; Goodman, L. A mild method for the hydrolysis of acetal groups attached to sugars and nucleosides. Carbohydr. Res. 1968, 7 (7), 507-509.
28. (a) Dehouck Dehouck, M.P.; Méresse, S.B.; Fruchart, J.C.; Cecchelli, R. In vitro reconstituted blood-brain barrier. J. Controlled Release. 1992, 21 (1-3), 81-91;
29. (b) Cecchelli, R.; Dehouck, B.; Descamps, L.; Fenart, L.; Buée-Scherrer, V.; Duhem, C.; Rentfel, M.; Torpier, G.; Dehouck, M.P. In vitro model for evaluating drug transport across the blood-brain barrier. Adv. Drug Delivery Rev. 1999, 36 (2-3), 165-178.